ClinicalTrials.gov
ClinicalTrials.gov Menu

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01015300
Recruitment Status : Terminated (Study terminated due to low accrual.)
First Posted : November 18, 2009
Last Update Posted : May 11, 2012
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : April 2012